Staged bilateral focused ultrasound shows substantial, durable relief for Parkinson's disease in Lancet Neurology study

Insightec announced the publication of pivotal clinical trial results in The Lancet Neurology, demonstrating that staged bilateral MR-guided focused ultrasound (MRgFUS) treatment for Parkinson's disease produces substantial and durable improvements in disabling motor symptoms. Benefits were observed within one month of the incisionless procedure.